Armstrong Medical Ltd.

Amphastar Pharmaceuticals Inc. expects by July to try again with a new drug application to FDA to relaunch Primatene Mist OTC emergency asthma inhaler after receiving an agency "green light" on a c

Amphastar Pharmaceuticals Inc. expects by July to try again with a new drug application to FDA to relaunch Primatene Mist OTC emergency asthma inhaler after receiving an agency "green light" on a c

Amphastar Pharmaceuticals Inc. keeps its eye on the goal of making its asthma inhaler Primatene Mist available OTC again as a second complete response letter from FDA pushes the finish line back f

Amphastar Pharmaceuticals Inc. keeps its eye on the goal of making its asthma inhaler Primatene Mist available OTC again as a second complete response letter from FDA pushes the finish line back f